Thursday, September 24, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.8
The broader S&P 500 is in a sharp, widespread drawdown, with most constituents down double digits over the trailing month and 15-40% below their 52-week highs, consistent with a significant market correction or risk-off event. However, a clear pocket of strength has emerged in AI-linked semiconductors, cybersecurity, and life-science instrument makers, several of which are back within a few percent of their 52-week highs with strong 5-day and 30-day returns, suggesting a rotation into quality growth names even as the index broadly de-rates.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | DHR | SKIP | — | $222.69 → $234.06 stop $203.54 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | INTC | SKIP | — | $124.48 → $131.10 stop $111.53 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #3 | FTNT | SKIP | — | $179.31 → $189.07 stop $162.45 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #4 | IQV | SKIP | — | $272.95 → $286.60 stop $254.12 |
Position cap reached — 60 of 20 slots in use. |
Already open: GILD (to Sep 25), ANET (to Sep 26), AMZN (to Sep 26), MSFT (to Sep 27), IMI.L (to Sep 30), NOW (to Oct 1), HSX.L (to Oct 1), LSEG.L (to Oct 1), ADM (to Oct 2), MCK (to Oct 2), BEZ.L (to Oct 2), BIIB (to Oct 3) … and 48 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Danaher makes lab and diagnostic instruments used by hospitals and biotech researchers, another name benefiting from the current rotation into life-sciences equipment makers. Its price recently accelerated (+6% in just five days) and is trading above both its short- and long-term trend lines, with a solid four-quarter earnings-beat streak. The key risk is that its overall outperformance versus the market is the thinnest of this group, so it has less of a buffer if the broader selloff resumes.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Intel makes computer chips and is trying to rebuild its manufacturing business to compete with rivals like TSMC. The company just posted its strongest revenue growth in over 15 years and blew past Wall Street's profit estimate, and the CEO personally bought $10 million of stock. The main risk is that Intel reports its next earnings before this trade would close, which adds an all-or-nothing news event to the mix.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Fortinet sells cybersecurity hardware and software that businesses use to protect their networks. The stock is trending strongly higher, beating the broader market by a wide margin, and its price is holding above its key moving averages with healthy (not overheated) momentum. The main risk is that several top executives, including the CEO, have been selling a lot of stock recently, which can sometimes signal they think shares are fully valued.
Why the AI likes it
What could go wrong
Calibrated probability: 60% (raw model estimate: 71%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
IQVIA runs clinical trials and data analytics for pharmaceutical companies, part of the life-sciences pocket of strength holding up while the broader market slides. Its price is squeezed tightly between technical support and resistance, which often precedes a breakout move, and it's trading above its key moving averages. The main risks are that its recent outperformance versus the market is thinner than other picks, and its momentum indicator (MACD) is showing early signs of losing steam.
Why the AI likes it
What could go wrong
Calibrated probability: 60% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 24, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.